Lucid Diagnostics launches EsoGuard 2.0 for esophageal precancer detection
The EsoGuard Esophageal DNA test is intended to help in preventing cancer and associated death through early detection…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Nov 23
The EsoGuard Esophageal DNA test is intended to help in preventing cancer and associated death through early detection…
10 Nov 23
The acquisition will greatly enhance and expand technology solutions platform in the minimally invasive and interventional therapies sector
10 Nov 23
New Partnership Paves the Way for Early Diagnosis and Intervention to Improve Cardiovascular Outcomes & Quality of Life…
09 Nov 23
AceConnex is a device intended for soft tissue surgical procedures, in which constructs are used for reconstruction, replacement,…
09 Nov 23
After the realignment, Acutus Medical will operate as a contract manufacturing company with the potential to generate positive…
09 Nov 23
The capability of the guidewire is designed to assist the collecting and processing of large amounts of data…
09 Nov 23
Otsuka and Ai-BrainScience will proceed with procedures for health insurance coverage and launch the program as soon as…
09 Nov 23
Neurolutions is a medical technology company dedicated to transforming the lives of patients suffering from neurological conditions
09 Nov 23
KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use subcutaneous drug delivery systems that improve quality of…
08 Nov 23
Veracyte will offer its high-performing molecular tests as decentralised IVD tests on Illumina’s NextSeq 550Dx next-generation sequencing (NGS)…